◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

First Trust Germany AlphaDEX Fund (FGM) ETF Overview

Name: First Trust Germany AlphaDEX Fund (FGM) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Focused Region · DATA UPDATED 2026-08-31

First Trust Germany AlphaDEX Fund (FGM) is an exchange-traded fund managed by First Trust in the "Focused Region" category. It manages roughly $98 million in assets.

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.

Interactive chart & fund stats →

FGM Fund Statistics

Expense ratio	0.80%
Trailing yield	1.40%
Assets under management	$98 million
Fund category	Focused Region
Fund family	First Trust
Inception	2012-02-14

The live price chart, fund profile and news are in the interactive FGM viewer.

Other Companies in Focused Region

EPHE · iShares MSCI Philippines ETF — $141 million
IZRL · ARK Israel Innovative Technology ETF — $137 million
MKOR · Matthews Korea Active ETF — $127 million
FLLA · Franklin FTSE Latin America ETF — $111 million
AFK · VanEck Africa Index ETF — $97 million
ENOR · iShares MSCI Norway ETF — $96 million
NORW · Global X MSCI Norway ETF — $88 million
FLMX · Franklin FTSE Mexico ETF — $86 million

← FGL All “F” companies FGNX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.